Bayer CEO on Lower Earnings, Monsanto Purchase, Roundup

The transcript discusses the market reaction to the Monsanto acquisition, highlighting growth in earnings and strategic benefits. It addresses concerns about the Roundup verdict, emphasizing the safety of glyphosate and the company's commitment to defending its product. The speaker expresses confidence in the acquisition's long-term benefits and outlines plans to appeal the legal verdict.

What evidence does the company provide to support the safety of glyphosate?

What are the company's plans following the jury's verdict regarding Roundup?

How does the company plan to address the concerns raised by the jury's decision?